[BRIEF SUMMARY OF CLOSED DEAL EXTRACTED FROM 8-KA] https://www.sec.gov/Archives/edgar/data/1081938/000168316819000030/0001683168-19-000030-index.htm
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Date of Report (Date of earliest event reported):
November 19, 2018
2 Park Plaza, Suite 1200-B, Irvine, CA 92614
On or about November 21, 2018, we filed a report on Form 8-K, advising that we had entered into a Securities Purchase Agreement to acquire Alternative Medical Solutions, Inc., an Ontario, Canada corporation (“AMS”). The purpose of this amended report is to advise that all conditions to closing of this acquisition have been satisfied. This amended report also includes the audited financial statements of AMS, along with unaudited pro forma financial statements of the consolidated surviving entity. The contents of the original Form 8-K are incorporated herein as if set forth, except as revised or qualified in this amendment.
Item 1.01 Entry into a Material Definitive Agreement
As we previously reported, effective November 19, 2018, we entered into a Securities Purchase Agreement with Alternative Medical Solutions, Inc., an Ontario, Canada corporation (“AMS”), its shareholders and Hanover CPMD Acquisition Corp., wherein we have now acquired all of the issued and outstanding securities of AMS.